Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

JAVELIN PHARMACEUTICALS, INC (JAV) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $0.15 Metrics
OS: 60.6 M
Market cap: $8.85 M
Net cash: $1.07 M $0.02 per share
EV: $7.79 M

 
TTM Valuation
EBITDA
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-09Dec-31-08Dec-31-07Dec-31-06Dec-31-05Dec-31-04Dec-31-03
Revenues3,820.11,101.619.00.87.24.82,216.4
            Revenue growth246.8%5692.2%2158.3%-88.3%50.1%-99.8% 
Cost of goods sold2,978.7849.638.010.95.74.01,114.0
Gross profit841.4252.0-19.0-10.01.50.81,102.4
            Gross margin22.0%22.9%-100.0%-1188.8%21.5%17.4%49.7%
Selling, general and administrative13,248.617,219.513.89.65.22.7 
General and administrative      2,013.4
EBIT-37,218.2-44,091.6-32.9-19.7-10.9-6.7-3,151.8
            EBIT margin-974.3%-4002.5%-173.1%-2337.0%-151.6%-139.5%-142.2%
Pre-tax income-37,565.6-43,446.6-31.0-17.8-10.6-7.0-3,155.1
Income taxes11.816.50.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%
Net income-37.6-43.50.00.00.00.0-3.2
            Net margin-1.0%-3.9%-0.2%-2.1%-0.1%-0.1%-0.1%
 
Diluted EPS($0.62)($0.77)($0.68)($0.44)($0.38)$0.00($0.32)
Shares outstanding (diluted)61.056.20.00.00.010,936.99.9
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy